glp-1 agonist for prediabetes Receptor Agonists: An Alternative Rapid-Acting Insulin? Indications for GLP-1/GIP RA Summary
Description
Owen, R
The data was triangulated by studying various factors and trends from both the demand and supply sides
Evidence that tirzepatide protects against diabetes-related cardiac damages
Conclusion The emergence of lower-cost GLP-1 therapies could mark a major turning point in diabetes management
Patients with gastroparesis should be screened for the presence of diabetes mellitus, thyroid dysfunction, neurological disease, prior gastric or bariatric surgery and autoimmune disorders
